3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Tumor-Agnostic
1
Other neoplasm
1
Conditions
Precancerous Conditions
6
Uterine Cervical Neoplasms
5
Uterine Cervical Dysplasia
5
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Papillomavirus Infections
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Cyclophosphamide
2
Busulfan
2
Bone Marrow Transplantation
2
tirbanibulin
1
ruxolitinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Toremifene
1
Tomography, Optical Coherence
1
Pregnancy Tests
1
Pemetrexed
1
Human Papillomavirus DNA Tests
1
Gastroscopes
1
Endoscopic Mucosal Resection
1
Colposcopy
1
CPI-0610
1
Biopsy
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Colposcopy
×
Other neoplasm
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled